Q4 2025 · 13F-HR
AIGH Capital Management LLCholdings as filed
Filed 2026-02-02 · accession 0001214659-26-001042
$413.1M
Reported value
34
Positions
2025-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 80004C200 | SNDK | SANDISK CORP | $66.5M | 16.1% | 280,000 | Common | SOLE |
| 98980L901 | — | ZOOM COMMUNICATIONS INC | $60.4M | 14.6% | 700,000 | CALL | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $24.3M | 5.88% | 624,719 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $23.1M | 5.59% | 2,900,000 | Common | SOLE |
| 65487K100 | LASR | NLIGHT INC | $22.5M | 5.45% | 600,103 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS | $18.6M | 4.49% | 1,992,021 | Common | SOLE |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $17.6M | 4.27% | 1,998,431 | Common | SOLE |
| 05587G203 | BKTI | BK TECHNOLOGIES CORPORATION | $15.8M | 3.82% | 211,453 | Common | SOLE |
| 257554105 | DOMO | DOMO INC | $15.5M | 3.75% | 1,837,762 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC | $14.8M | 3.58% | 4,000,000 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $14.1M | 3.41% | 1,500,000 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $12.2M | 2.95% | 1,581,501 | Common | SOLE |
| 532257805 | LPTH | LIGHTPATH TECHNOLOGIES INC | $11.1M | 2.69% | 1,030,738 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $10.5M | 2.55% | 2,000,000 | Common | SOLE |
| 488445906 | ZVRA | ZEVRA THERAPEUTICS INC | $9.0M | 2.17% | 1,000,000 | CALL | SOLE |
| 45817G201 | IDN | INTELLICHECK INC | $8.1M | 1.96% | 1,213,434 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $7.6M | 1.84% | 2,000,000 | Common | SOLE |
| 00770C101 | ARQ | ARQ INC | $7.4M | 1.80% | 2,273,092 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $6.7M | 1.62% | 1,150,000 | Common | SOLE |
| 12448X201 | BYRN | BYRNA TECHNOLOGIES INC | $6.6M | 1.60% | 394,906 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $5.8M | 1.41% | 1,342,972 | Common | SOLE |
| 22407B108 | COYA | COYA THERAPEUTICS INC | $5.7M | 1.37% | 975,404 | Common | SOLE |
| G7997R903 | STX | SEAGATE TECHNOLOGY HLDNGS | $5.5M | 1.33% | 20,000 | CALL | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $5.3M | 1.29% | 4,661,502 | Common | SOLE |
| 03837C106 | APYX | APYX MEDICAL CORPORATION | $3.9M | 0.94% | 1,104,970 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $3.7M | 0.89% | 2,833,894 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $3.1M | 0.76% | 907,217 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $2.1M | 0.51% | 3,068,185 | Common | SOLE |
| 64134X201 | NRXS | NEURAXIS INC | $1.8M | 0.44% | 400,000 | Common | SOLE |
| 451622203 | IPWR | IDEAL PWR INC | $1.5M | 0.37% | 491,989 | Common | SOLE |
| 83193D203 | SMTK | SMARTKEM INC | $718,875 | 0.17% | 675,000 | Common | SOLE |
| 74907L409 | QNRX | QUOIN PHARMACEUTICALS LTD | $711,731 | 0.17% | 49,323 | Common | SOLE |
| 09077D209 | BFRI | BIOFRONTERA INC | $521,670 | 0.13% | 915,210 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $316,071 | 0.08% | 370,541 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.